Greenville Health System Cancer Institute-Spartanburg is a clinical research site located in Spartanburg, South Carolina, United States 29307.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Greenville Health System Cancer Institute-Spartanburg has participated in 71 clinical trials with 10 currently active.
Therapeutic areas: Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer.
Sponsors: Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Greenville Health System Cancer Institute-Spartanburg has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Greenville Health System Cancer Institute-Spartanburg has 71 clinical trials on record, with 10 currently active. Their work covers Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer.
Greenville Health System Cancer Institute-Spartanburg has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.